Date: Tue 29/03/2022 - Fri 29/03/2024
Optometrist Credits: 0.75 general credits
Event Type(s): Online
Topical intraocular lowering therapies are associated with varied ocular and systemic adverse effects; they can cause drug interactions and impact on co-morbidities.
Unaddressed adverse events can compromise adherence, treatment outcomes and potentially, patients’ health. Selecting effective and well tolerated drugs is an important
consideration in the management of glaucoma. Recognising susceptibility to adverse
events, early identification and appropriate intervention, markedly improves outcomes.
This article discusses a few important common and less common adverse effects associated with frequently used classes of anti-glaucoma drugs, as well as strategies to minimise or prevent adverse events.